Eplus SEC Filings

Ira A. Hunt, a Director of EPLUS INC (PLUS), received a grant of 1,478 restricted shares of common stock on 10/01/2025 under the company's 2024 Non-Employee Director Long Term Incentive Plan. The award was granted at a reported price of $0 and is subject to a restriction period that ends on the first anniversary of the grant, during which the shares may vest early under certain plan conditions or be forfeited.

Following the grant, Mr. Hunt beneficially owned 27,806 shares. The Form 4 was signed by the reporting person on 10/03/2025. The filing discloses the grant terms and the existence of the restriction period but contains no additional financial metrics, transaction consideration beyond the $0 reported price, or changes to prior holdings other than the post-grant ownership total.

John E. Callies, a director of EPLUS INC (PLUS), received a grant of 1,478 restricted shares of the company's common stock on 10/01/2025 under the 2024 Non-Employee Director Long Term Incentive Plan. The award was granted at no cash price ($0) and is subject to a restriction period that ends on the first anniversary of the grant, during which the shares may vest or be forfeited under the plan's terms. Following the grant, Mr. Callies beneficially owns 21,988 shares.

The transaction was reported on a Form 4 and signed by the reporting person. The grant increases the director's ownership stake while imposing a one-year restriction period designed to align his interests with shareholders during that term.

Bruce M. Bowen, a director of ePlus Inc. (PLUS), reported several transactions dated 10/01/2025 on Form 4. He received a grant of 1,478 restricted shares under the company’s 2024 Non-Employee Director Long Term Incentive Plan that vest after a one-year restriction period. On the same date he transferred 2,687 shares from his personal account to the Bruce Montague Bowen Trust for no consideration; he is the trustee and sole beneficiary and remains the beneficial owner of those shares. He was also issued 300 shares by election in lieu of cash compensation. The Form lists various post-transaction holdings, including 4,165 shares shown as direct ownership and 15,213 shares held indirectly by the trust.

ePlus Inc. (PLUS) reported a Form 4 for Director Renee Bergeron. On 10/01/2025, she acquired 1,478 shares of common stock at $0 as a restricted stock award, increasing her directly held shares to 5,772.

The award was granted under the Company’s 2024 Non-Employee Director Long Term Incentive Plan and is subject to a Restriction Period ending on the first anniversary of the grant. Under certain circumstances described in the plan, restrictions may lapse or the shares may be forfeited and transferred back to the Company.

Melissa J. Ballenger, a director of EPLUS INC (PLUS), was granted 1,478 shares of restricted common stock on 10/01/2025 under the company’s 2024 Non-Employee Director Long Term Incentive Plan. The award carries a one‑year restriction period that begins on the grant date, after which restrictions may lapse or, under certain circumstances described in the plan, the shares may be forfeited and returned to the company. Following this grant, Ms. Ballenger beneficially owns 2,525 shares. The reported acquisition price is $0, and the Form 4 was signed on 10/03/2025.

ePlus Inc. reported the results of its shareholder votes held in connection with its proxy. All director nominees were elected by shareholders. An advisory vote on executive compensation was approved with 20,889,682 votes for, 2,422,490 against and 63,233 abstentions; there were 1,048,860 broker non-votes. Shareholders also ratified the selection of Deloitte & Touche LLP as the company’s independent registered accounting firm for fiscal year 2026, with 23,891,323 votes for, 528,043 against and 4,899 abstentions.